BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34205185)

  • 1. PLS-DA Model for the Evaluation of Attention Deficit and Hyperactivity Disorder in Children and Adolescents through Blood Serum FTIR Spectra.
    Ogruc Ildiz G; Karadag A; Kaygisiz E; Fausto R
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34205185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourier Transform Infrared Spectroscopy Based Complementary Diagnosis Tool for Autism Spectrum Disorder in Children and Adolescents.
    Ogruc Ildiz G; Bayari S; Karadag A; Kaygisiz E; Fausto R
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults.
    Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R
    Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder is associated with reduced levels of serum low-density lipoprotein cholesterol in adolescents. Data from the population-based German KiGGS study.
    Pinho R; Wang B; Becker A; Rothenberger A; Outeiro TF; Herrmann-Lingen C; Meyer T
    World J Biol Psychiatry; 2019 Jul; 20(6):496-504. PubMed ID: 29243550
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attention-deficit hyperactivity disorder or bipolar disorder in childhood?].
    Lazaratou H
    Psychiatriki; 2012; 23(4):304-13. PubMed ID: 23399752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychiatric comorbidities of adults with early- and late-onset attention-deficit/hyperactivity disorder.
    Lin YJ; Yang LK; Gau SS
    Aust N Z J Psychiatry; 2016 Jun; 50(6):548-56. PubMed ID: 26460330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inattention and hyperactive/impulsive component scores do not differentiate between autism spectrum disorder and attention-deficit/hyperactivity disorder in a clinical sample.
    Krakowski AD; Cost KT; Anagnostou E; Lai MC; Crosbie J; Schachar R; Georgiades S; Duku E; Szatmari P
    Mol Autism; 2020 Apr; 11(1):28. PubMed ID: 32334619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does collateral retrospective information about childhood attention-deficit/hyperactivity disorder symptoms assist in the diagnosis of attention-deficit/hyperactivity disorder in adults? Findings from a large clinical sample.
    Breda V; Rovaris DL; Vitola ES; Mota NR; Blaya-Rocha P; Salgado CA; Victor MM; Picon FA; Karam RG; Silva KL; Rohde LA; Bau CH; Grevet EH
    Aust N Z J Psychiatry; 2016 Jun; 50(6):557-65. PubMed ID: 26460329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Is emotional dysregulation a component of attention-deficit/hyperactivity disorder (ADHD)?].
    Villemonteix T; Purper-Ouakil D; Romo L
    Encephale; 2015 Apr; 41(2):108-14. PubMed ID: 24703785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiols and ceruloplasmin levels in serum of children with attention deficit hyperactivity disorder: A cross-sectional study.
    Öğütlü H; Mertoğlu C; Gök G; Neşelioğlu S
    Psychiatry Res; 2020 Dec; 294():113546. PubMed ID: 33160216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
    Otasowie J; Castells X; Ehimare UP; Smith CH
    Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The course of attention deficit hyperactivity disorder (ADHD) over the life span].
    Koumoula A
    Psychiatriki; 2012 Jun; 23 Suppl 1():49-59. PubMed ID: 22796973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the autistic traits in children and adolescents diagnosed with attention-deficit hyperactivity disorder and their parents.
    Okyar E; Görker I
    BMC Psychiatry; 2020 Jun; 20(1):285. PubMed ID: 32503560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the test of variables of attention reliable for the diagnosis of attention-deficit hyperactivity disorder (ADHD)?
    Zelnik N; Bennett-Back O; Miari W; Goez HR; Fattal-Valevski A
    J Child Neurol; 2012 Jun; 27(6):703-7. PubMed ID: 22378668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings.
    Leslie LK; Weckerly J; Plemmons D; Landsverk J; Eastman S
    Pediatrics; 2004 Jul; 114(1):129-40. PubMed ID: 15231919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attention deficit-hyperactivity disorder is associated with reduced blood pressure and serum vitamin D levels: results from the nationwide German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
    Meyer T; Becker A; Sundermann J; Rothenberger A; Herrmann-Lingen C
    Eur Child Adolesc Psychiatry; 2017 Feb; 26(2):165-175. PubMed ID: 27197525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the childhood symptom profile of community-based individuals diagnosed with attention-deficit/hyperactivity disorder as adults.
    Taylor MJ; Larsson H; Gillberg C; Lichtenstein P; Lundström S
    J Child Psychol Psychiatry; 2019 Mar; 60(3):259-266. PubMed ID: 30338854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.